CYS-002 Investigational Site — Andover, Massachusetts

CYS-002 Investigational Site is a clinical research site located in Andover, Massachusetts, United States 01810.

Crixeo Clinical Trials Trust Score: 14/100 (FAILING). This profile has not yet been claimed by the site owner.

CYS-002 Investigational Site has participated in 4 clinical trials.

Therapeutic areas: Dry Eye Syndromes, Dry Eye Disease (DED), Dry Eye Disease.

Sponsors: Novaliq GmbH.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Andover

Browse all research sites in Massachusetts · View every site in Andover

Sponsor Feasibility Report

Trust Score: 14/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for CYS-002 Investigational Site?

CYS-002 Investigational Site has a Crixeo Trust Score of 14/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has CYS-002 Investigational Site conducted?

CYS-002 Investigational Site has 4 clinical trials on record. Their work covers Dry Eye Syndromes, Dry Eye Disease (DED), Dry Eye Disease.

Is CYS-002 Investigational Site accredited by Crixeo Clinical Trials?

CYS-002 Investigational Site has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about CYS-002 Investigational Site?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.